This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, R. S.
Right arrow Articles by Spinola, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, R. S.
Right arrow Articles by Spinola, S. M.

 Previous Article  |  Next Article 

Infection and Immunity, December 1999, p. 6335-6340, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Expression of Sialylated or Paragloboside-Like Lipooligosaccharides Are Not Required for Pustule Formation by Haemophilus ducreyi in Human Volunteers

Royden S. Young,1 Kate Fortney,1 Jennifer C. Haley,2 Antoinette F. Hood,1,2 Anthony A. Campagnari,3 Jing Wang,4 Joel A. Bozue,4 Robert S. Munson Jr.,4,5 and Stanley M. Spinola1,6,7,*

Departments of Medicine,1 Microbiology and Immunology,6 Pathology and Laboratory Medicine,7 and Dermatology,2 Indiana University School of Medicine, Indianapolis, Indiana 46202; Department of Microbiology, State University of New York at Buffalo, New York 142143; and Children's Research Institute4 and Department of Pediatrics and Department of Medical Microbiology and Immunology,5 Ohio State University, Columbus, Ohio 43205-2696

Received 1 July 1999/Returned for modification 16 August 1999/Accepted 13 September 1999

The lipooligosaccharide (LOS) of Haemophilus ducreyi, the etiologic agent of chancroid, chemically and immunologically resembles human glycosphingolipid antigens. To test whether LOS that contains paragloboside-like structures was required for pustule formation, an isogenic mutant (35000HP-RSM2) was constructed in losB, which encodes D-glycero-D-manno-heptosyltransferase. 35000HP-RSM2 produces a truncated LOS whose major glycoform terminates in a single glucose attached to a heptose trisaccharide core and 2-keto-3-deoxyoctulosonic acid. Five human subjects were inoculated with 35000HP and 35000HP-RSM2 in a dose-response trial. For estimated delivered doses (EDDs) of >= 25 CFU, the pustule formation rates were 80% for 35000HP and 58% for 35000HP-RSM2. Preliminary data indicated that a previously described Tn916 losB mutant made a minor glycoform that does not require DD-heptose to form the terminal N-acetyllactosamine. If 35000HP-RSM2 made this glycoform, then 35000HP-RSM2 could theoretically make a sialylated glycoform. To test whether sialylated LOS was required for pustule formation, a second trial comparing an isogenic sialyltransferase mutant (35000HP-RSM203) to 35000HP was performed in five additional subjects. For EDDs of >= 25 CFU, the pustule formation rates were 30% for both 35000HP and 35000HP-RSM203. The histopathology and recovery rates of H. ducreyi from surface cultures and biopsies obtained from mutant and parent sites in both trials were similar. These results indicate that neither the expression of a major glycoform resembling paragloboside nor sialylated LOS is required for pustule formation by H. ducreyi in humans.


* Corresponding author. Mailing address: Department of Medicine, 435 Emerson Hall, 545 Barnhill Dr., Indiana University, Indianapolis, IN 46202-5124. Phone: (317) 274-1427. Fax: (317) 274-1587. E-mail: sspinola{at}iupui.edu.


Infection and Immunity, December 1999, p. 6335-6340, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Post, D. M. B., Munson, R. S. Jr., Baker, B., Zhong, H., Bozue, J. A., Gibson, B. W. (2007). Identification of Genes Involved in the Expression of Atypical Lipooligosaccharide Structures from a Second Class of Haemophilus ducreyi. Infect. Immun. 75: 113-121 [Abstract] [Full Text]  
  • Abdullah, M., Nepluev, I., Afonina, G., Ram, S., Rice, P., Cade, W., Elkins, C. (2005). Killing of dsrA Mutants of Haemophilus ducreyi by Normal Human Serum Occurs via the Classical Complement Pathway and Is Initiated by Immunoglobulin M Binding. Infect. Immun. 73: 3431-3439 [Abstract] [Full Text]  
  • Cole, L. E., Toffer, K. L., Fulcher, R. A., San Mateo, L. R., Orndorff, P. E., Kawula, T. H. (2003). A Humoral Immune Response Confers Protection against Haemophilus ducreyi Infection. Infect. Immun. 71: 6971-6977 [Abstract] [Full Text]  
  • Spinola, S. M., Fortney, K. R., Katz, B. P., Latimer, J. L., Mock, J. R., Vakevainen, M., Hansen, E. J. (2003). Haemophilus ducreyi Requires an Intact flp Gene Cluster for Virulence in Humans. Infect. Immun. 71: 7178-7182 [Abstract] [Full Text]  
  • Spinola, S. M., Bong, C. T. H., Faber, A. L., Fortney, K. R., Bennett, S. L., Townsend, C. A., Zwickl, B. E., Billings, S. D., Humphreys, T. L., Bauer, M. E., Katz, B. P. (2003). Differences in Host Susceptibility to Disease Progression in the Human Challenge Model of Haemophilus ducreyi Infection. Infect. Immun. 71: 6658-6663 [Abstract] [Full Text]  
  • Tullius, M. V., Phillips, N. J., Scheffler, N. K., Samuels, N. M., Munson, R. S. Jr., Hansen, E. J., Stevens-Riley, M., Campagnari, A. A., Gibson, B. W. (2002). The lbgAB Gene Cluster of Haemophilus ducreyi Encodes a {beta}-1,4-Galactosyltransferase and an {alpha}-1,6-DD-Heptosyltransferase Involved in Lipooligosaccharide Biosynthesis. Infect. Immun. 70: 2853-2861 [Abstract] [Full Text]  
  • Spinola, S. M., Bauer, M. E., Munson, R. S. Jr. (2002). Immunopathogenesis of Haemophilus ducreyi Infection (Chancroid). Infect. Immun. 70: 1667-1676 [Full Text]  
  • Bong, C. T. H., Fortney, K. R., Katz, B. P., Hood, A. F., Mateo, L. R. S., Kawula, T. H., Spinola, S. M. (2002). A Superoxide Dismutase C Mutant of Haemophilus ducreyi Is Virulent in Human Volunteers. Infect. Immun. 70: 1367-1371 [Abstract] [Full Text]  
  • Gelfanova, V., Humphreys, T. L., Spinola, S. M. (2001). Characterization of Haemophilus ducreyi-Specific T-Cell Lines from Lesions of Experimentally Infected Human Subjects. Infect. Immun. 69: 4224-4231 [Abstract] [Full Text]  
  • Young, R. S., Filiatrault, M. J., Fortney, K. R., Hood, A. F., Katz, B. P., Munson, R. S. Jr., Campagnari, A. A., Spinola, S. M. (2001). Haemophilus ducreyi Lipooligosaccharide Mutant Defective in Expression of {beta}-1,4-Glucosyltransferase Is Virulent in Humans. Infect. Immun. 69: 4180-4184 [Abstract] [Full Text]  
  • Throm, R. E., Spinola, S. M. (2001). Transcription of Candidate Virulence Genes of Haemophilus ducreyi during Infection of Human Volunteers. Infect. Immun. 69: 1483-1487 [Abstract] [Full Text]  
  • Young, R. S., Fortney, K. R., Gelfanova, V., Phillips, C. L., Katz, B. P., Hood, A. F., Latimer, J. L., Munson, R. S. Jr., Hansen, E. J., Spinola, S. M. (2001). Expression of Cytolethal Distending Toxin and Hemolysin Is Not Required for Pustule Formation by Haemophilus ducreyi in Human Volunteers. Infect. Immun. 69: 1938-1942 [Abstract] [Full Text]  
  • Fortney, K. R., Young, R. S., Bauer, M. E., Katz, B. P., Hood, A. F., Munson, R. S. Jr., Spinola, S. M. (2000). Expression of Peptidoglycan-Associated Lipoprotein Is Required for Virulence in the Human Model of Haemophilus ducreyi Infection. Infect. Immun. 68: 6441-6448 [Abstract] [Full Text]  
  • Throm, R. E., Al-Tawfiq, J. A., Fortney, K. R., Katz, B. P., Hood, A. F., Slaughter, C. A., Hansen, E. J., Spinola, S. M. (2000). Evaluation of an Isogenic Major Outer Membrane Protein-Deficient Mutant in the Human Model of Haemophilus ducreyi Infection. Infect. Immun. 68: 2602-2607 [Abstract] [Full Text]  
  • Bauer, M. E., Spinola, S. M. (2000). Localization of Haemophilus ducreyi at the Pustular Stage of Disease in the Human Model of Infection. Infect. Immun. 68: 2309-2314 [Abstract] [Full Text]